Drugs / Iron Supplement
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT03171324 | Mar 2017 → Sep 2018 | iron deficiency anemia | Deepanjan Bhattacharya | Unknown | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT00213161 | Aug 2004 → Jun 2005 | anemia | The Hospital for Sick Children | Completed | No outcome recorded |
| — | NCT00094042 | Jan 2002 → Jul 2007 | premature aging syndrome | National Institute on Aging (NIA) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iron Supplement | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03171324 ↗ |
| Route | Oral | “receive oral iron supplementation from 6 weeks and 6 months.” NCT03171324 ↗ |